Mr. Ofer Haviv
President and Chief Executive Officer
Ofer Haviv holds the position of Evogene's President and CEO as of late 2004. Prior to that he held the positions of company COO and CFO from 2002 to 2004 and was involved in Evogene's spin-off from Compugen in 2002. At Compugen, he held the position of Director of Finance and Treasurer of Compugen (NASDAQ: CGEN) for four years, during which time the company completed two private placements and an IPO on NASDAQ
Mr. Haviv holds a B.A. degree in Economics and Accounting from Faculty of Management, Tel Aviv University and is a Certified Public Accountant in Israel.email@example.com
Dr. Hagai Karchi
Chief Technology Officer and Head of R&D Crop Enhancement
Dr. Karchi is co-founder of Evogene and served as its CEO from 2002 to 2004. Prior to the spin-off of Evogene from Compugen he was the Co-Head of Compugen's Plant Genomic Division. He has over 15 years experience in the breeding of tomatoes and in molecular genomics research. His scientific achievements include the development of a molecular system for gene discovery and the development of high yielding, high quality greenhouse tomato varieties. Dr. Karchi has lectured widely in the field of plant genomics and has an extensive record of publications and patents.
Dr. Karchi holds B.Sc and M.Sc degrees from the Hebrew University of Jerusalemױs Faculty of Agriculture, specializing in gene expression. He holds a Ph.D. from The Weizmann Institute of Science and the Hebrew University of Jerusalem, Israel.firstname.lastname@example.org
Mr. Assaf Oron
Executive Vice President Corporate Development
Assaf joined Evogene in 2006 and since then led the company's business development and strategy efforts. In 2015 Assaf was appointed as Executive Vice President Corporate Development. Prior to joining Evogene, Assaf was CEO of ChondroSite, a biotechnology company that develops tissue engineered products in the field of orthopedics. Prior to ChondroSite, Assaf worked at Glenrock, a private investment company, overseeing various biotechnology related ventures, and led several strategic consulting roles at POC, a leading Israeli management consulting firm.
Assaf holds an M.Sc. degree in Biology and a B.Sc. degree in Economics and Chemistry from Tel Aviv University.email@example.com
Mr. Assaf Kacen
Chief Operation Officer
Mr. Kacen leads Evogene’s Technology Platform, overseeing the company’s core R&D, field and greenhouse experiments, computational genomics and data management platforms, plant research laboratories and high-throughput validation systems, all of which form the implementation layer of the company’s research and development programs. Prior to joining Evogene, Mr. Kacen held senior product management positions at Nokia Siemens Networks where he gained substantial R&D management experience leading multi-disciplinary teams across several broad scope projects.
Mr. Kacen holds an MBA from Interdisciplinary Center, Herzlia, majoring in Finance, and a B.Sc in Communication Systems Engineering from Ben-Gurion University.firstname.lastname@example.org
Mr. Eyal Leibovitz
Chief Financial Officer
Mr. Leibovitz has over 25 years of experience in senior management, finance, IR, M&A and business development in international companies.
Prior to joining Evogene, during the years 2011 to 2015 Mr. Leibovitz served as CFO of N-trig Ltd., an electronic inking company. Prior to this, from 2007 to 2011 Mr. Leibovitz served as the CFO of Kamada Ltd. (NASDAQ & TASE: KMDA), a leading biopharmaceutical company. From 2002 to 2007 Mr. Leibovitz served as the International controller of Harmonic Inc. (NASDAQ:HLIT), operating in the digital video space. From 1997 to 2002 Mr. Leibovitz co-founded and was the CFO of New Media Communications which was later sold to Harmonic.
Mr. Leibovitz holds a BBA degree from the City University of New York.email@example.com
Dr. Eyal Emmanuel
Chief Science Officer and Head of R&D Crop Protection
Dr. Emmanuel joined Evogene in May 2006, and since that time has held various R&D management positions at the Company, most recently as Vice President R&D of the Company’s Ag-Chemicals division. Prior to joining Evogene, Dr. Emmanuel served as a researcher at Life Science Research Israel, Israel’s premier life sciences research center.Eyal.Emmanuel@evogene.com
Dr. Emmanuel holds a B.Sc. from the Hebrew University, Faculty of Agriculture and an M.Sc.and Ph.D from the Weizmann Institute of Science. Dr. Emmanuel also holds an MBA, from the College of Management in Israel, majoring in Bio-Medical Management.
Mr. Ido Dor
Executive Vice President & General Manager Crop Enhancement
Ido was appointed as Executive Vice President & General Manager Crop Enhancement in November 2015. Mr. Dor joined Evogene in 2011 as a Director of Business Development and led the business activity of the Ag Chemicals division. Since 2015 he is leading Evogene’s Ag Biologicals activity, overseeing research, development and business aspects. Prior to joining Evogene, Ido headed the Israeli Small & Mid-Size Enterprise business activity at SAP, the world leading organizational software company. Prior to his role at SAP, Ido led a business unit at Niram Gitan Group, a leading Israeli management-consulting firm.
Mr. Dor holds an MBA degree and a B.Sc. degree in Industrial Engineering - both from Tel Aviv University.Ido.firstname.lastname@example.org
Mr. Eran Kosover
Executive Vice President & General Manager Crop Protection
Mr. Kosover was appointed as Executive Vice President & General Manager Crop Protection in November 2015.Prior to this position, Mr. Kosover served as Evogene’s VP Project Management, where his team was in charge of managing all collaborations and internal projects in the company, and prior to that as a Business Development Manager in Evogene. Prior to Evogene, Mr. Kosover was in charge of Sales, Business Development and Operations in Atera, an Israeli Hi-tech start-up in the field of SMB IT. Prior to Atera, Mr. Kosover worked as a Project Manager in various Strategic Consulting projects for Teva Pharmaceuticals.Eran.Kosover@evogene.com
Mr. Kosover holds an M.A. in Economics from the Tel Aviv University Berglas School of Economics (2006); and a B.A. in Economics and Management from the Tel Aviv University (2002).